Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG
(Wegovy, Zepbound, or Foundayo only) Pregnancy and breastfeeding - speak with your provider if you are or plan to be pregnant or breastfeeding, as these GLP-1 agonists should only be used during pregnancy or breastfeeding if the potential benefit outweighs potential risk to the fetus or breastfed infant
[PMID: 4457555] PubMed record related to this compound for laboratory literature review
Patients report Semaglutide success stories of losing up to 15% of their body weight within six months
Others find the injection requirement a meaningful barrier to long-term adherence
On the other hand, it can also be very overwhelming